NICOLE LEGER: Open Payments
NPI 1013296169 · TAUNTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 17 payments from 10 companies in 2025. Trend: 2023 $233 · 2024 $399 · 2025 $493
Food & beverage: $493
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 1 | $113 |
| Novo Nordisk Inc | 4 | $95 |
| Novartis Pharmaceuticals Corporation | 4 | $66 |
| AstraZeneca Pharmaceuticals LP | 2 | $60 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Lilly USA, LLC | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Aimmune Therapeutics, Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: INSPIRE, LEQVIO, FARXIGA, Wegovy, DUPIXENT, MOUNJARO, Ozempic, Kerendia.
Industry payments across MA — which companies pay providers there.
